Fornstedt, B., Pileblad, E
Monthly Cost Breakdown: Annual Cost Comparison: For Cash-Pay Patients (No Insurance Coverage): Savings Scenarios: Scenario 1: Currently Paying Full Price for Mounjaro Situation: No insurance or insurance doesnt cover Paying $1,069/month for Mounjaro Need medication for 18 months to reach goal weight Current Cost: 18 months $1,069 = $19,242 Switching to Compounded Tirzepatide: 18 months $349 = $6,282 Total Savings: $12,960 Switching to Compounded Semaglutide: 18 months $199 = $3,582 Total Savings: $15,660 Scenario 2: High Insurance Copays Situation: Insurance covers Mounjaro but with $250/month copay Deductible of $3,000 not yet met First 3 months paying full price, then copays Current Cost: 3 months $1,069 (deductible) = $3,207 15 months $250 (copay) = $3,750 Total 18 months: $6,957 Switching to Compounded Tirzepatide: 18 months $349 = $6,282 Total Savings: $675 Plus no insurance hassles, prior authorizations, or coverage uncertainty Scenario 3: No Access to Mounjaro Situation: Mounjaro out of stock at all local pharmacies Been waiting 2 months for availability Weight loss journey stalled Current Cost: Zero progress toward health goals Continued health risks from obesity Frustration and lost momentum Switching to Compounded Tirzepatide: Immediate access within 3-7 days Resume weight loss progress $349/month for treatment vs
Prostate Cancer A systematic review by You et al
PLoS One 12 , e0171781 (2017)
Our study emphasizes a potential association between insulin deficiency and SGLT2 inhibitor-associated hyDKA evidenced by high glucose levels and decreased C-peptide concentrations
